Medication info

Rosutap 20 mg (Rosuvastatin Calcium)

Prescription medicationExpired
Ingredient · strength
Rosuvastatin Calcium›Strength being verified
Manufacturer / importer
Shin Shin Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Expired

MFDS item code 201803719 · Approved 2018.09.14

This product's status changed to Expired on 2023.09.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of the progression of atherosclerosis
Who uses it
Adults
Adult dosage
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is required. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams once daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with use in patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. In some of these patients, administration of the 40 milligrams dose of this medicine is contraindicated.

Ingredients

Manufacturer
Shin Shin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of the progression of atherosclerosis

  • Hypercholesterolemia
  • hyperlipidemia
  • familial hypercholesterolemia
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of premature coronary artery disease
View approved original text

This medication is used as an adjunctive agent in cases of primary hypercholesterolemia and combined hyperlipidemia that are difficult to control with diet and exercise. It is also helpful for patients with homozygous familial hypercholesterolemia along with dietary measures or other lipid-lowering therapies. In patients with hypercholesterolemia, it effectively lowers total cholesterol and LDL cholesterol levels, slowing the progression of atherosclerosis. It is also used as an adjunct to dietary measures in patients with primary dysbetalipoproteinemia. In middle-aged or older patients at high risk for cardiovascular disease, it helps reduce the risk associated with stroke, myocardial infarction, and arterial revascularization. In summary, this medication is effectively used for various forms of hyperlipidemia and reduction of cardiovascular disease risk.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is required. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams once daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with use in patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. In some of these patients, administration of the 40 milligrams dose of this medicine is contraindicated.

Precautions

This drug should not be administered to certain patients. For example, it should not be used in those with allergies to any of its components, severely impaired liver function, muscle disorders, patients taking certain immunosuppressants, those with severe renal impairment, pregnant or nursing women, and patients with genetic lactose intolerance. Caution is advised when using this drug in patients with a history of heavy alcohol use or liver disease, and regular liver function tests should be conducted. Additionally, if symptoms such as muscle pain or weakness occur, the patient should inform their doctor immediately, and patients at high risk of muscle damage should undergo regular muscle enzyme tests before and during treatment. This drug may increase blood concentration when taken with certain medications, raising the risk of muscle damage, so dosage adjustments or discontinuation may be necessary when used with specific drugs. Caution is particularly needed when combined with fibrate-class medications. Women of childbearing potential should use appropriate contraceptive methods while taking this medication, and this drug should not be used during pregnancy. It may be transmitted through breast milk; therefore, nursing mothers should also avoid using it. In case of overdose, there is no specific antidote, so treatment should be based on symptoms, and liver function and muscle enzyme levels should be monitored. Dizziness may occur during the use of this drug, so caution is advised when driving or operating machinery. While taking this drug, it is important to regularly check liver and muscle health status and consult medical personnel immediately if any abnormal symptoms arise.

Side effects

Hypersensitivity reactions, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, cough, shortness of breath, diarrhea, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, joint pain, fatigue, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distention, abnormal liver function tests, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to keep it at room temperature between 1 degree and 30 degrees Celsius. This way of storage helps maintain the effectiveness of the medication and prevents degradation.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.